NOVONIX lets 460K performance rights lapse

NOVONIX Ltd cancelled 460,452 unvested performance rights on September 18, 2026, with no consideration paid, and detailed its updated issued capital structure.

Rhea-AI Filing Summary

NOVONIX Ltd (NVX) reported the lapse of 460,452 NVXAD Performance Rights on September 18, 2026, after conditions for these conditional rights were not met or became incapable of being satisfied. No consideration was paid in connection with this cessation. Following this change, issued capital includes 997,852,692 NVX ordinary fully paid shares on issue, and unquoted equity securities comprising 20,729,515 NVXAD Performance Rights, 14,016,667 NVXAA options, 1,371,566 NVXAB share rights, and 45,221,586 NVXAL convertible notes.

Key Figures

Performance rights lapsed: 460,452 NVXAD Performance Rights Ordinary shares on issue: 997,852,692 NVX ordinary fully paid shares Remaining NVXAD Performance Rights: 20,729,515 NVXAD Performance Rights +5 more

8 metrics

Performance rights lapsed 460,452 NVXAD Performance Rights Ceased on September 18, 2026 due to unmet or incapable conditions

Ordinary shares on issue 997,852,692 NVX ordinary fully paid shares Quoted equity securities on issue after the reported cessation

Remaining NVXAD Performance Rights 20,729,515 NVXAD Performance Rights Unquoted equity securities on issue after the lapse

Options on issue 14,016,667 NVXAA options Unquoted options expiring on various dates at various prices

Share rights on issue 1,371,566 NVXAB share rights Unquoted equity securities on issue

Convertible notes on issue 45,221,586 NVXAL convertible notes Unquoted equity securities on issue

Announcement date September 18, 2026 Date of Appendix 3H notification regarding cessation of securities

Consideration for cessation None Entity stated it is not paying any consideration for the cessation

Key Terms

Performance Rights, convertible notes, issued capital, +securities, +1 more

5 terms

Performance Rights financial

"NVXAD PERFORMANCE RIGHTS 460,452 Lapse of conditional right"

Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.

convertible notes financial

"NVXAL CONVERTIBLE NOTES 45,221,586"

Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.

issued capital financial

"We provide the following information about our issued capital."

+securities financial

"Details of +securities that have ceased"

unquoted +equity securities financial

"Unquoted +equity securities that have ceased"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity securities ceased according to NOVONIX (NVX)'s September 2026 Form 6-K?

NOVONIX reported that 460,452 NVXAD Performance Rights ceased on September 18, 2026. These performance rights lapsed because the conditions for the conditional rights were not met or had become incapable of being satisfied.

Did NOVONIX (NVX) pay any consideration for the cessation of the 460,452 performance rights?

No. NOVONIX stated that it is not paying any consideration for the cessation of the 460,452 NVXAD Performance Rights that lapsed on September 18, 2026.

What is NOVONIX (NVX)'s total ordinary share capital after the performance rights lapse?

Following the lapse of the performance rights, NOVONIX reported 997,852,692 NVX ordinary fully paid shares on issue. The company noted that these figures are used by ASX to calculate its total market capitalisation.

How many NVXAD performance rights does NOVONIX (NVX) have outstanding after this change?

After the cessation of 460,452 rights, NOVONIX reported 20,729,515 NVXAD Performance Rights remaining on issue as unquoted equity securities.

What other unquoted equity securities does NOVONIX (NVX) have on issue?

NOVONIX listed unquoted equity securities of 14,016,667 NVXAA options, 1,371,566 NVXAB share rights, and 45,221,586 NVXAL convertible notes, in addition to the remaining NVXAD performance rights.

On what date did NOVONIX (NVX) announce the cessation of these performance rights to ASX?

NOVONIX gave the announcement date as September 18, 2026 for the Appendix 3H notification to ASX covering the cessation of the 460,452 NVXAD Performance Rights.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/21/2026 - 07:15 AM EDT Accepted by SEC EDGAR 09/21/2026 - 07:14 AM EDT Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of September, 2026

001-41208

(Commission File Number)

NOVONIX LIMITED

(Translation of registrant’s name into English)

Level 38

71 Eagle Street

Brisbane, QLD 4000 Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40‑F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

EXHIBIT INDEX

Exhibit No.		Description
Exhibit 99.1		Appendix 3H (Notification of cessation of securities) dated September 18, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NOVONIX LIMITED
By:	/s/ Mike O'Kronley
	Mike O'Kronley
	Chief Executive Officer

Date: September 21, 2026

Appendix 3H - Notification of cessation of securities

EXHIBIT 99.1

Announcement Summary

Entity name

NOVONIX LIMITED

Announcement Type

New announcement

Date of this announcement

Friday September 18, 2026

Details of +securities that have ceased

			Number of
	ASX +security		+securities that	The +securities have	Date of
	code	Security description	have ceased	ceased due to	cessation
	NVXAD	PERFORMANCE RIGHTS	460,452	Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied	18/09/2026

Refer to next page for full details of the announcement

Appendix 3H - Notification of cessation of securities 1 / 4

Appendix 3H - Notification of cessation of securities

Part 1 - Announcement Details

1.1 Name of +Entity

NOVONIX LIMITED

We (the entity named above) provide the following information about our issued capital.

1.2 Registered Number Type	Registration Number
ABN	54157690830
1.3 ASX issuer code NVX
1.4 The announcement is New announcement
1.5 Date of this announcement 18/9/2026

Appendix 3H - Notification of cessation of securities 2 / 4

Appendix 3H - Notification of cessation of securities

Part 2 - Details of +equity securities or +debt securities that have ceased

ASX +Security Code and Description

NVXAD : PERFORMANCE RIGHTS

Unquoted +equity securities that have ceased Number of securities that have ceased

460,452

Reason for cessation

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

Date of cessation	Is the entity paying any consideration for the cessation?
18/9/2026	No

Any other information the entity wishes to notify to ASX about the cessation?

Lapse of employee performance rights on cessation of employment.

Appendix 3H - Notification of cessation of securities 3 / 4

Appendix 3H - Notification of cessation of securities

Part 3 - Issued capital following changes

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:

The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)

ASX +security code and description	Total number of +securities on issue
NVX : ORDINARY FULLY PAID	997,852,692

3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)

ASX +security code and description	Total number of +securities on issue
NVXAD : PERFORMANCE RIGHTS	20,729,515
NVXAA : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES	14,016,667
NVXAB : SHARE RIGHTS	1,371,566
NVXAL : CONVERTIBLE NOTES	45,221,586

NVXAH : CONVERTIBLE DEBENTURES 35,000,000

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

Appendix 3H - Notification of cessation of securities 4 / 4

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EX-99.1 67.9 KB